Ear Nose & throat
Sandoz launches allergy relief nasal spray in Germany and Switzerland
April 9, 2026Ear Nose & throat
Sandoz has launched its azelastine and fluticasone fixed-dose-combination (FDC) nasal spray in Germany and Switzerland. In Germany the FDC over …
ENA Respiratory doses first patients with INNA-051 antiviral nasal spray
February 17, 2026Ear Nose & throat, Ena Respiratory
ENA Respiratory, a clinical-stage biopharmaceutical company specialising in the prevention of viral respiratory infections, has announced the first dosing of …
Eli Lilly’s tirzepatide demonstrates efficacy in reducing sleep apnoea severity
April 18, 2024Research and Development Ear Nose & throat, Eli Lilly, clinical trial, sleep apnoea, tirzepatide
Eli Lilly has announced positive topline results from its SURMOUNT-OSA phase 3 trials which demonstrated that tizepatide injection (10mg or …
Regeneron and Sanofi’s sBLA for Dupixent accepted by FDA for priority review
September 26, 2023Medical Communications Dupixent, Ear Nose & throat, FDA, Regeneron, Sanofi
Regeneron Pharmaceuticals and Sanofi have announced that the US Food and Drug Administration (FDA) has accepted their supplemental Biologics License …
ZOLL remedē System receives FDA approval for sleep apnoea treatment
May 25, 2023Medical Communications Ear Nose & throat, FDA, ZOLL, sleep apnoea
ZOLL Medical Corporation has announced that it has received approval from the US Food and Drug Administration (FDA) for its …
FDA accepts sNDA for Optinose’s XHANCE
May 5, 2023Medical Communications Ear Nose & throat, FDA, Nasal Spray, optinose, sNDA
Optinose has announced that the US Food and Drug Administration (FDA) has accepted a supplemental new drug application (sNDA) for …
FDA approves Pfizer’s pneumococcal conjugate vaccine for infants and children
April 28, 2023Market Access, Research and Development, Sales and Marketing Ear Nose & throat, FDA, Immunology, Pfizer, Vaccine, pneumococcal vaccine
Pfizer has announced that the US Food and Drug Administration (FDA) has approved its PREVNAR 20 (20-valent pneumococcal conjugate vaccine) …
